Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-03-15

FDA Approved: ZIAGEN — Supplemental Application (ViiV Healthcare Company)

View source ↗

Summary

FDA approves a supplemental application for ZIAGEN (abacavir sulfate) filed by ViiV Healthcare Company. The action relates to the drug's labeling changes for HI…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ziagen (Abacavir)

Snippet

SUPPL AP for ZIAGEN (ABACAVIR SULFATE)